Article
04 Feb 2026
OIG Issues Special Advisory Bulletin On DTC Prescription Drug Sales To Federal Health Care Program Enrollees
AUTHORS CONTENT
Article
25 Nov 2024
The 2025 Final Hospital Outpatient Prospective Payment System And Physician Fee Schedule Rules: What Pharma Stakeholders Need To Know
Article
15 Mar 2021
Passage Of American Rescue Plan Act Of 2021 Could Mean Larger Medicaid Drug Rebate Program Rebates For Pharmaceutical Manufacturers
Article
31 Dec 2020
Second Judge Grants Temporary Injunction Against Favored Nation Rule
Article
30 Dec 2020
Early Christmas Presents For Pharmaceutical Manufacturers: Court Grants Temporary Ban On Medicare Part B Most Favored Nations Reimbursement Rule
Article
29 Nov 2020
CMS Releases Interim Final Rule Establishing Reimbursement For Part B Drugs Based On International Pricing
Article
26 Nov 2020
Discount Safe Harbor Final Rule Released: OIG Seeks To Adopt Major Changes
Article
20 Nov 2020
OIG Issues Fraud Alert: Should Pharma And Device Companies Cease Speaker Programs?
Article
10 Nov 2020
340B Entities Sue HHS Over Lack Of Dispute Resolution Process
Article
05 Oct 2018
It's About More Than Hospitals: CY 2019 Proposed Hospital Outpatient Prospective Payment System Rule Contains Proposals Of Interest To The Pharmaceutical Industry
Article
11 Oct 2014
OIG Proposes New Safe Harbors to Anti-Kickback Statute
Article
07 Oct 2014
Local Drug Take-Back Law Creates Regulatory Burden For Manufacturers
Article
26 Sep 2014
OIG Finds Commercial Drug Copay Coupons Are Being Used By Medicare Part D Beneficiaries And Warns Of Anti-Kickback Statute Exposure
Article
04 Aug 2014
OIG Issues Favorable Advisory Opinion To Pharmaceutical Manufacturer On Direct-To-Patient Discount Sales Program
Article
23 May 2014
OIG Releases Supplemental Guidance For Bona Fide, Charitable Patient Assistance Programs
Article
26 Apr 2014
Tales From The Unencrypted: DHHS Steps Up Enforcement Of Unsecured Electronic Devices